Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularityAntje Arnold, Eric H. Raabe, Lauren Harris et al.|Neuro-Oncology|2019Cited by 36
LGG-51. METABOLIC PROFILING IN PEDIATRIC LOW GRADE GLIOMA IDENTIFIES GLUTATHIONE DEPLETION AFTER MTORC1 INHIBITION AND VALIDATES EVEROLIMUS AND CARBOPLATIN AS A POTENTIAL COMBINATION THERAPYBrad Poore, Eric H. Raabe, Ming Yuan et al.|Neuro-Oncology|2018Cited by 1